Why the study?
Timely diagnosis and treatment of CTEPH are often hampered by nonspecific symptoms and signs and a lack of physician awareness.
This review highlights the clinical features and multimodal imaging diagnostic processes for chronic thromboembolic pulmonary hypertension to improve timely diagnosis.
Answers are grounded in this paper and cite their sources.
Multimodal imaging may aid timely CTEPH diagnosis; extends diagnostic literature but leaves optimal algorithms open for prospective validation.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but life-threatening pulmonary vascular disease caused by the presence of a prolonged thrombus in the pulmonary artery. CTEPH is a distinct disease entity classified as group 4 pulmonary hypertension according to the World Symposium on Pulmonary Hypertension. It is the only potentially curable cause of pulmonary hypertension. However, timely diagnosis and treatment are often hampered by nonspecific symptoms and signs and a lack of physician awareness regarding the condition. Thus, it is important to be familiar with the clinical features of CTEPH and the associated diagnostic processes. Herein, we cover the diagnostic approach for CTEPH using multimodal imaging tools in a clinical setting.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: